Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Operating Expenses (2020 - 2025)

Historic Operating Expenses for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $23.8 million.

  • NeuroPace's Operating Expenses rose 2087.68% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.1 million, marking a year-over-year increase of 1451.75%. This contributed to the annual value of $80.8 million for FY2024, which is 725.14% up from last year.
  • NeuroPace's Operating Expenses amounted to $23.8 million in Q3 2025, which was up 2087.68% from $25.0 million recorded in Q2 2025.
  • NeuroPace's 5-year Operating Expenses high stood at $25.0 million for Q2 2025, and its period low was $12.4 million during Q1 2021.
  • In the last 5 years, NeuroPace's Operating Expenses had a median value of $18.7 million in 2022 and averaged $18.8 million.
  • The largest annual percentage gain for NeuroPace's Operating Expenses in the last 5 years was 5748.28% (2021), contrasted with its biggest fall of 118.26% (2021).
  • NeuroPace's Operating Expenses (Quarter) stood at $17.1 million in 2021, then grew by 9.19% to $18.7 million in 2022, then decreased by 0.35% to $18.6 million in 2023, then rose by 6.69% to $19.8 million in 2024, then rose by 19.79% to $23.8 million in 2025.
  • Its Operating Expenses stands at $23.8 million for Q3 2025, versus $25.0 million for Q2 2025 and $22.5 million for Q1 2025.